Company Information

  

Address: LEVEL 12, 95 PITT STREET  
City: SYDNEY, NEW SOUTH WALES 
State:  
Zip Code: 2000 
Telephone: 612 9276 1224 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Our legal and commercial name is Prima BioMed Ltd. We were incorporated under the laws of the Commonwealth of Australia on May 21, 1987. 21 -------------------------------------------------------------------------------- Table of Contents Our registered office is located at Level 12, 95 Pitt Street, Sydney 2000 New South Wales, Australia and our telephone number is +61 (0)2 8315 7003. Our address on the Internet is www.primabiomed.com.au. The information on, or accessible through, our website is not part of this Annual Report on Form 20-F. We have included our website address in this Annual Report on Form 20-F solely as an inactive textual reference. Fiscal 2016 On 29 June 2015 Prima BioMed announced a Notice of Meeting for the Extraordinary General Meeting to be held in Sydney on 31 July 2015. The EGM resolutions were in regards to the acquisition of Immutep SA, and, US-based Ridgeback Capital Investments.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2016-30.77NAN/E

Key Financial Ratios and Statistics

FYE: 06/30

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.05Total Liab/Total Assets0.24
Net Inc/Total Assets-0.27Total Liab/Inv Cap0.26
Net Inc/Inv Cap-0.29Total Liab/Comm Equity0.04
Pretax Inc/Net Sales-2.45Interest Coverage RatioNA
Net Inc/Net Sales-2.28Curr Debt/EquityNA
Cash Flow/Net Sales-2.07LTD/Equity0.22
SG&A/NetSales1.06Total Debt/Equity0.22
Asset Utilization   Liquidity  
Net Receivables Turnover3.49Quick Ratio6.05
Inventory TurnoverNACurrent Ratio6.05
Inventory Day SalesNANet Rec/Curr Assets0.14
Net Sales/Work Cap0.31Inv/Curr AssetsNA
Net Sales/PP&E170.10  

Income Statement (Millions)

  6/30/2017 6/30/2016 6/30/2015 6/30/2014
Total Revenues(Net Sales) 3.16 1.31 1.03 1.91
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 3.33 40.54 4.40 3.86
Operating Income -7.25 -45.97 -11.28 -13.64
Interest Exp 0.00 0.01 14.12 0.00
Pretax Income -7.75 -47.06 -24.82 -12.58
Other Income -0.50 -1.08 0.58 1.06
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -7.19 -46.18 -24.71 -12.59

Balance Sheet (Millions)

Assets 6/30/2017 6/30/2016 6/30/2015 6/30/2014
Cash & Short Term Investments 9.39 15.55 5.20 21.90
Receivables - Total 1.68 0.13 0.24 0.19
Inventories - Total NA NA NA NA
Total Current Assets 12.21 16.14 6.17 23.30
Net Property, Plant & Equipment 0.02 0.02 0.23 0.54
Total Assets 26.82 31.69 23.81 23.95
Liabilities        
Accounts Payable 2.02 1.10 2.21 2.62
Debt in Current Liabilities NA NA 1.16 0.00
Total Current Liabilities 2.02 1.10 3.37 2.62
Long-Term Debt 4.43 3.74 0.00 NA
Total Liabilities 6.47 5.39 4.84 2.63
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 149.85 144.85 138.26 140.65
Retained Earnings -177.83 -165.65 -123.33 -121.10
Treasury Stock NA NA NA NA
Total Stockholders' Equity 20.35 26.30 18.98 21.32
Total Liabilities and Stockholders' Equity 26.82 31.69 23.81 23.95

Cash Flow Summary (Millions)

Categories 6/30/2017 6/30/2016 6/30/2015 6/30/2014
Net Cash Provided by Operating Activities -6.53 -8.42 -5.99 -13.43
Net Cash Provided by Investing Activities -0.01 0.08 -9.19 -1.04
Net Cash Provided by Financing Activities -0.01 19.15 8.66 6.31

Annual Summary Data (Millions)

Year Sales Net Income EPS
06/20131.51-13.94--
06/20141.91-12.59--
06/20151.03-24.71--
06/20161.31-46.18-30.77
06/20173.16-7.19--
Growth Rates20.27----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/179920.39




Report Date : 11/27/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.